If You Stop Mounjaro, Will You Gain Weight Back?

Why regain happens: the biology behind stopping tirzepatide

Mounjaro (tirzepatide) acts on two gut-hormone receptors (GIP and GLP-1) that play a central role in regulating appetite and how quickly the stomach empties. While you are on treatment, the medicine is doing a lot of the physiological heavy lifting: making you feel full sooner, reducing hunger signals between meals, and moderating the speed at which food moves through your gut. When you stop taking it, those effects stop too.

The body does not simply stay in its new, lower-weight state. For many people, hunger returns to something closer to its pre-treatment level within weeks. The NHS patient information for tirzepatide notes that tirzepatide works on these appetite pathways continuously, it is not a course of treatment that 're-sets' the body permanently. That distinction matters when you are trying to understand what stopping actually means.

It also helps to understand that obesity itself involves persistent biological signals pushing weight back up after a loss, signals that exist independently of whether you were ever on medication. Tirzepatide counteracts some of those signals; when the medicine is gone, those underlying pressures reassert themselves. You can read more about the broader picture of weight and tirzepatide if you want a fuller explanation of the mechanisms involved.

What the trial data actually shows about stopping

The evidence here is sobering but worth knowing clearly rather than vaguely. In a tirzepatide extension study, participants who stopped treatment after achieving substantial weight loss regained a meaningful portion of that weight within the following year, while those who continued treatment maintained, and often extended, their losses. The pattern is consistent with what has been observed across the GLP-1 class and is discussed in NICE's appraisal of tirzepatide (TA1026), which underpins the UK clinical guidance for this medicine.

To put numbers on it without overstating them: in the SURMOUNT programme (involving thousands of adults across its trials) stopping tirzepatide typically resulted in roughly half to two-thirds of weight lost being regained within a year, depending on lifestyle factors maintained during that period. That is not a reason to feel hopeless about stopping if stopping is the right decision for your circumstances; it is simply the picture you deserve to have.

If you are curious about what weight loss looks like while on treatment, the page on typical weight loss outcomes with Mounjaro goes into the trial figures in more detail.

The decision to stop: what factors actually matter

This is where the framing shifts from information to decision. Stopping Mounjaro is not always the wrong call, there are genuine reasons people do it, from side effects they cannot tolerate, to planned surgery, to pregnancy, to simply wanting to try managing without medication after building solid habits. The question is whether the decision is made with a clear view of the likely consequences.

The factors that seem to make the biggest difference to how much weight is regained are: how established your eating and activity habits are by the time you stop; whether you have a specific plan for the first few weeks, when hunger signals tend to return most sharply; and whether you have some form of ongoing clinical or dietetic support. None of those guarantee you will hold your losses, but they shift the odds in a meaningful direction.

People who have built genuine behaviour changes during treatment tend to fare better than those who relied primarily on the medicine's appetite suppression without changing their broader patterns. That is an honest finding, not a moral judgement. If you stopped Mounjaro and are already seeing weight returning after stopping, there is a dedicated page on what that looks like and what the options are.

It is also worth knowing that many people find the prospect of stopping genuinely anxious-making, particularly after working hard to lose weight. That feeling makes sense. The clinical reality is that there is no permanent 'lock-in' from stopping, and if you want to understand why weight gain can occur on Mounjaro as well as after it, that page covers the full picture and may help you plan your next steps with a prescriber.

If you are thinking about stopping or have already stopped

Whether you are still on treatment and considering coming off, or whether you have already stopped and want to know how to limit regain after Mounjaro, the starting point is the same: a clinical conversation. Your prescriber can review where you are, what you have achieved, and whether a managed step-down, a planned pause, or continued treatment makes most sense for you right now.

Mounjaro is a prescription-only medicine, which means that stopping it (like starting it) is something your prescribing team should know about. Abrupt stops without a plan are where most of the avoidable regain happens. If you are not currently under a prescriber's care and want a clinical view, you can also explore what a consultation with our prescribers involves, it is free, with no commitment to treatment.

For context on what private treatment costs and what is included in a single transparent price, the weight-loss treatment overview covers that clearly, without any hidden fees to untangle.